Mesa Laboratories Inc earnings per share and revenue
On Feb 03, 2026, MLAB reported earnings of 3.07 USD per share (EPS) for Q3 26, beating the estimate of 0.28 USD, resulting in a 987.88% surprise. Revenue reached 65.13 million, compared to an expected 64.63 million, with a 0.78% difference. The market reacted with a +8.73% price change (close before vs. close after earnings).
Looking ahead to Q4 26, 5 analysts forecast an EPS of 0.36 USD, with revenue projected to reach 65.77 million USD, implying an decrease of -88.27% EPS, and increase of 0.98% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Accuray Incorporated
Report Date
Feb 04, 2026 For Q2 26
Estimate
-$0.11
Actual
-$0.11
Surprise
+1.96%
Thermo Fisher Scientific, Inc.
Report Date
Jan 29, 2026 For Q4 25
Estimate
$6.51
Actual
$6.57
Surprise
+0.91%
Intuitive Surgical Inc.
Report Date
Jan 22, 2026 For Q4 25
Estimate
$2.30
Actual
$2.52
Surprise
+9.86%
Idexx Laboratories Inc
Report Date
Feb 02, 2026 For Q4 25
Estimate
$2.98
Actual
$3.08
Surprise
+3.12%
STERIS plc
Report Date
Feb 04, 2026 For Q3 26
Estimate
$2.55
Actual
$2.52
Surprise
-0.99%
Hologic Inc
Report Date
Jan 29, 2026 For Q1 26
Estimate
$1.11
Actual
$1.04
Surprise
-6.45%
FAQ
What were Mesa Laboratories Inc's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Mesa Laboratories Inc reported EPS of $3.07, beating estimates by 987.88%, and revenue of $65.13M, 0.78% above expectations.
How did the market react to Mesa Laboratories Inc's Q3 2026 earnings?
The stock price moved up 8.73%, changed from $80.50 before the earnings release to $87.53 the day after.
When is Mesa Laboratories Inc expected to report next?
The next earning report is scheduled for May 26, 2026.
What are the forecasts for Mesa Laboratories Inc's next earnings report?
Based on 5
analysts, Mesa Laboratories Inc is expected to report EPS of $0.36 and revenue of $65.77M for Q4 2026.